American Marconi Wireless News - Greece nixes Acropolis shoot for 'Poor Things' director

NYSE - LSE

CMSC	-1.04%	22.01	$
RBGPF	100%	63	$
NGG	-0.05%	73	$
CMSD	-0.22%	22.3	$
SCS	-0.91%	9.92	$
BCE	1.48%	22.25	$
RELX	1.54%	54.63	$
JRI	-0.15%	12.91	$
RIO	-2.49%	59.4	$
BCC	-1.31%	93.28	$
RYCEF	-2.5%	10	$
GSK	2.21%	39.85	$
BTI	1.58%	43.55	$
AZN	0.11%	71.79	$
VOD	1.84%	9.76	$
BP	-2.22%	27.46	$

Greece nixes Acropolis shoot for 'Poor Things' director / Photo: Angelos TZORTZINIS - AFP/File

Greece nixes Acropolis shoot for 'Poor Things' director

TECHNOLOGY 04.04.2025

Greece's culture ministry has declined a request by the Greek director of the Oscar-winning "Poor Things" to film at the Acropolis, saying the scenes did not align with the storied site's image.

Text size:

Yorgos Lanthimos is one of Greece's best-known film makers, directing the 2024 hit "Poor Things" that won four Oscars, including Best Acress for Hollywood star Emma Stone.

Lanthimos, 51, whose work has also won numerous awards in the United States and Europe, had asked to film some scenes from his new movie, a sci-fi comedy called "Bugonia" also starring Stone, at the Acropolis in April.

But the culture ministry said in a statement on Thursday that it had refused permission because "the proposed scenes are incompatible with the symbolism ... and the values the Acropolis represents."

Greek media have reported that the scenes in question involved dead bodies strewn around the Acropolis rock.

The ministry said it had suggested alternative outdoor locations near the monument, Greece's best-known archaeological site.

"Bugonia" is slated to be released in November.

P.M.Smith--AMWN

American Marconi Wireless News - Greece nixes Acropolis shoot for 'Poor Things' director

Greece nixes Acropolis shoot for 'Poor Things' director

Featured

Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences

AuthX Secure is Now Available in Toolbox on Epic Showroom, Powering Secure Access for Providers

FiberLight Secures $500 Million Sustainability-Linked Refinancing to Accelerate Growth and Expand Digital Infrastructure

enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24